Luís Force
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 4
-
- Pneumonia and Respiratory Infections 4
- Influenza Virus Research Studies 2
- Co-authors
- Vicente Martín (5 shared papers)Mikel Egurrola (6 shared papers)Peré Domingo (3 shared papers)Francisco Sanz (6 shared papers)Diana Toledo (6 shared papers)Ángela Domı́nguez (5 shared papers)Jesús Castilla (6 shared papers)Jenaro Astray (6 shared papers)
In The Last Decade
Luís Force
26 papers receiving 782 citations
Luís Force's Hit Papers
Peers
Comparison fields: 5 of 59
- Infectious Diseases 466
- Virology 49
- Hepatology 62
- Endocrinology 25
- Pathology and Forensic Medicine 96
Countries citing papers authored by Luís Force
This map shows the geographic impact of Luís Force's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Force with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Force more than expected).
Fields of papers citing papers by Luís Force
This network shows the impact of papers produced by Luís Force. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Force. The network helps show where Luís Force may publish in the future.
Co-authors
The 25 scholars most cited alongside Luís Force, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials Hit paper breakdown → | 2018 | 313 |
| 2 | 1992 | 105 | |
| 3 | 2001 | 34 | |
| 4 | 2016 | 34 | |
| 5 | 2006 | 33 | |
| 6 | 2015 | 32 | |
| 7 | 2011 | 30 | |
| 8 | 2007 | 25 | |
| 9 | 2021 | 22 | |
| 10 | 2016 | 21 | |
| 11 | 2022 | 21 | |
| 12 | 2018 | 20 | |
| 13 | 2017 | 19 | |
| 14 | 2019 | 16 | |
| 15 | 2004 | 14 | |
| 16 | 2015 | 13 | |
| 17 | 2017 | 13 | |
| 18 | 2021 | 12 | |
| 19 | 2005 | 10 | |
| 20 | 2014 | 8 |
About Luís Force
Luís Force is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Pharmacology and Endocrinology, having authored 26 papers that have together received 826 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (4 papers), Pneumonia and Respiratory Infections (4 papers), Hepatitis C virus research (3 papers), Drug-Induced Adverse Reactions (2 papers), Influenza Virus Research Studies (2 papers), Health Education and Validation (1 paper) and Parasitic infections in humans and animals (1 paper). The work is most often cited by research in Infectious Diseases (466 citations), Virology (49 citations), Hepatology (62 citations), Endocrinology (25 citations) and Pathology and Forensic Medicine (96 citations). Luís Force has collaborated with scholars based in Spain and Mexico. Frequent co-authors include Vicente Martín, Mikel Egurrola, Peré Domingo, Francisco Sanz, Diana Toledo, Ángela Domı́nguez, Jesús Castilla, Jenaro Astray, Hernando Knobel and Teresa Cabezas. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, European Respiratory Journal, Clinical Infectious Diseases and Allergy and Asthma Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.